Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Successful implant salvage of a delayed tibial megaprosthesis infection using continuous local antibiotic perfusion: a case report.

International journal of surgery case reports·2026
Same author

Decreased expression of Ly-1 antibody reactive clone (Lyar) triggers enhanced adipogenesis of bone marrow mesenchymal stromal cells in aged bone marrow.

PloS one·2026
Same author

Study of Sensory Evaluation of Bittering Agents for Establishing an Evaluation System of Bitterness.

Journal of food science·2026
Same author

Immunohistological Expression of Sclerostin in Metastatic Osteolytic Bone Tumors.

Anticancer research·2026
Same author

Immunohistochemical Expression and Clinicopathological Assessment of PD-1, PD-L1, NY-ESO-1, and MAGE-A4 Expression in Desmoid Tumor.

Anticancer research·2026
Same author

Osteoid Osteoma on the Distal Phalanx of the Ring Finger: A Rare Case Report.

Cureus·2025

Related Experiment Video

Updated: Aug 27, 2025

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.5K

Characterizing inflammatory markers in highly aggressive soft tissue sarcomas.

Kazuhiko Hashimoto1,2, Shunji Nishimura2, Yu Shinyashiki1,2

  • 1Department of Orthopedic Surgery, Kushimoto Municipal Hospital, Higashimuro-Gun, Wakayama, Japan.

Medicine
|October 1, 2022
PubMed
Summary

Hematologic inflammatory markers like C-reactive protein (CRP) and white blood cell (WBC) counts may indicate poor prognosis in aggressive soft tissue sarcomas (STSs). These markers correlate with higher tumor grade and SUVmax, suggesting their utility in predicting outcomes.

More Related Videos

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.1K
The In ovo CAM-assay as a Xenograft Model for Sarcoma
12:44

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

25.6K

Related Experiment Videos

Last Updated: Aug 27, 2025

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.5K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.1K
The In ovo CAM-assay as a Xenograft Model for Sarcoma
12:44

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

25.6K

Area of Science:

  • Oncology
  • Hematology
  • Medical Diagnostics

Background:

  • Prognosis for soft tissue sarcomas (STSs) is often poor, particularly for aggressive subtypes.
  • Detailed prognostic factors for STSs remain incompletely understood.
  • Hematologic inflammatory markers are increasingly recognized for their potential role in cancer prognostication.

Purpose of the Study:

  • To investigate the association between pretreatment hematologic inflammatory markers and prognostic factors in patients with STSs.
  • To identify potential predictive markers for aggressive STSs.

Main Methods:

  • Retrospective analysis of 22 STS patients.
  • Evaluation of pretreatment blood markers: C-reactive protein (CRP), albumin, neutrophil, lymphocyte, and white blood cell (WBC) counts, and neutrophil/lymphocyte (N/L) ratio.
  • Correlation of these markers with tumor characteristics (size, grade) and imaging findings (SUVmax).

Main Results:

  • C-reactive protein (CRP) level, neutrophil count, and WBC count showed positive correlations with higher tissue grade and SUVmax.
  • Neutrophil/lymphocyte (N/L) ratio was positively correlated with tumor size and SUVmax.
  • Elevated CRP, WBC, neutrophil counts, and N/L ratio were associated with aggressive STS features.

Conclusions:

  • Pretreatment CRP level, WBC count, neutrophil count, and N/L ratio may serve as indicators of poor prognosis in highly aggressive STSs.
  • These hematologic markers could aid in risk stratification and treatment planning for STS patients.
  • Further research is warranted to validate these findings in larger cohorts.